Acurx Pharmaceuticals (ACXP) Stock Chart & Stock Price History → This is the best new way to score with AI (From Weiss Ratings) (Ad) Free ACXP Stock Alerts $2.16 -0.09 (-4.00%) (As of 05:32 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Acurx Pharmaceuticals Stock Price Performance5 Day Performance+13.30%1 Month Performance+38.55%3 Month Performance-28.57%6 Month Performance-36.46%Year-To-Date Performance-39.95%1 Year Performance-26.75% Receive ACXP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Acurx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Weiss RatingsThis is the best new way to score with AIIf you thought that you missed your chance to score big on AI, I have great news. A rare second profit window is starting to open.Click now for the best way into the newest AI projects ACXP Stock Chart for Thursday, May, 16, 2024 ACXP Chart by TradingView Acurx Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/15/2024$2.09$2.25+7.66%$2.36$2.14170,421 shs$35.46 million05/14/2024$2.09$2.09$2.12$2.0254,337 shs$32.94 million05/13/2024$2.03$2.09+2.96%$2.11$2.0311,699 shs$32.94 million05/10/2024$2.02$2.03+0.50%$2.06$1.9916,796 shs$31.99 million05/09/2024$1.94$2.02+4.12%$2.04$1.8575,052 shs$31.84 million05/08/2024$1.97$1.94-1.52%$2.03$1.9020,197 shs$30.57 million Get the Latest News and Ratings for ACXP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Acurx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/07/2024$2.08$1.97-5.29%$2.09$1.9726,226 shs$31.05 million05/06/2024$2.17$2.08-4.15%$2.24$2.0441,098 shs$32.78 million05/03/2024$2.12$2.17+2.36%$2.21$2.1032,524 shs$34.20 million05/02/2024$2.16$2.12-1.85%$2.22$2.0625,534 shs$33.41 million05/01/2024$2.25$2.16-4.00%$2.32$2.1378,610 shs$34.67 million04/30/2024$2.19$2.25+2.74%$2.30$2.1034,435 shs$35.46 million04/29/2024$2.07$2.19+5.80%$2.33$2.0285,884 shs$34.51 million04/26/2024$2.02$2.07+2.48%$2.08$1.9828,594 shs$32.62 million04/25/2024$2.03$2.02-0.49%$2.13$1.9685,169 shs$31.84 million04/24/2024$2.04$2.03-0.49%$2.07$1.9716,633 shs$31.99 million04/23/2024$1.98$2.04+3.03%$2.05$1.9429,691 shs$32.15 million04/22/2024$2.01$1.98-1.49%$2.01$1.9051,986 shs$31.20 million04/19/2024$2.13$2.01-5.63%$2.17$1.9793,506 shs$31.68 million04/18/2024$1.80$2.13+18.33%$2.13$1.80141,555 shs$33.57 million04/17/2024$1.66$1.80+8.43%$1.84$1.62114,332 shs$28.37 million04/16/2024$1.64$1.66+1.53%$1.79$1.52247,497 shs$26.16 million04/15/2024$1.77$1.64-7.63%$1.82$1.6292,843 shs$25.77 million04/12/2024$1.87$1.77-5.35%$1.86$1.66172,233 shs$27.90 million04/11/2024$1.86$1.87+0.54%$1.91$1.8425,415 shs$29.47 million04/10/2024$1.93$1.86-3.63%$1.96$1.80106,244 shs$29.31 million04/09/2024$1.91$1.93+1.05%$1.95$1.8924,775 shs$30.42 million04/08/2024$1.93$1.91-1.04%$1.99$1.8877,001 shs$30.10 million04/05/2024$1.96$1.93-1.53%$1.95$1.8963,173 shs$30.42 million04/04/2024$2.00$1.96-2.00%$2.07$1.9453,847 shs$30.89 million04/03/2024$2.17$2.00-7.83%$2.19$1.98100,587 shs$31.52 million04/02/2024$2.28$2.17-4.82%$2.28$2.1465,977 shs$34.20 million04/01/2024$2.45$2.28-6.94%$2.43$2.2326,583 shs$35.93 million03/29/2024$2.45$2.45$2.48$2.3684,623 shs$38.61 million03/28/2024$2.33$2.45+5.15%$2.48$2.3684,600 shs$38.61 million03/27/2024$2.08$2.33+12.02%$2.44$2.0586,698 shs$36.72 million03/26/2024$2.09$2.08-0.48%$2.10$2.0260,098 shs$32.78 million03/25/2024$1.94$2.09+7.73%$2.14$1.93112,909 shs$32.94 million03/22/2024$2.06$1.94-5.83%$2.05$1.9283,988 shs$30.57 million03/21/2024$2.11$2.06-2.37%$2.16$1.84168,096 shs$32.47 millionCharles Payne Demystifies Options (Ad)When it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. Click here to register for free.03/20/2024$2.11$2.11$2.20$1.98119,991 shs$33.25 million03/19/2024$2.59$2.11-18.53%$2.39$2.11304,901 shs$29.05 million03/18/2024$2.72$2.59-4.78%$2.92$2.59172,235 shs$35.66 million03/15/2024$2.71$2.72+0.37%$2.92$2.70118,098 shs$37.45 million03/14/2024$2.80$2.71-3.21%$2.88$2.7043,056 shs$37.31 million03/13/2024$2.86$2.80-2.10%$2.90$2.8020,479 shs$38.56 million03/12/2024$2.84$2.86+0.70%$2.94$2.8122,570 shs$39.38 million03/11/2024$2.91$2.84-2.41%$2.98$2.8222,411 shs$39.11 million03/08/2024$2.97$2.91-2.02%$3.06$2.8223,377 shs$40.07 million03/07/2024$3.00$2.97-1.00%$3.02$2.9035,891 shs$40.90 million03/06/2024$2.99$3.00+0.33%$3.02$2.8044,510 shs$41.31 million03/05/2024$2.93$2.99+2.05%$3.05$2.8353,933 shs$41.17 million03/04/2024$2.96$2.93-1.01%$2.98$2.8336,782 shs$40.35 million03/01/2024$2.87$2.96+3.14%$3.17$2.8262,772 shs$40.76 million02/29/2024$2.92$2.87-1.71%$3.01$2.8066,923 shs$39.51 million02/28/2024$3.13$2.92-6.71%$3.18$2.8696,056 shs$40.21 million02/27/2024$3.25$3.13-3.69%$3.35$3.00180,520 shs$43.10 million02/26/2024$3.15$3.25+3.17%$3.29$3.0171,802 shs$44.75 million02/23/2024$3.13$3.15+0.64%$3.17$3.0257,174 shs$43.38 million02/22/2024$2.95$3.13+6.10%$3.19$2.9461,766 shs$43.10 million02/21/2024$2.92$2.95+1.03%$3.07$2.8587,487 shs$40.62 million02/20/2024$3.23$2.92-9.60%$3.26$2.8665,339 shs$40.21 million02/19/2024$3.23$3.23+0.16%$3.28$2.90315,200 shs$44.47 million02/16/2024$3.05$3.22+5.57%$3.28$2.90314,158 shs$44.34 million02/15/2024$2.99$3.05+2.01%$3.06$2.8756,102 shs$41.99 million Related Companies: NRx Pharmaceuticals Stock Price Chart BriaCell Therapeutics Stock Price Chart Fortress Biotech Stock Price Chart Aprea Therapeutics Stock Price Chart Spruce Biosciences Stock Price Chart Apollomics Stock Price Chart Daré Bioscience Stock Price Chart ImmunoPrecise Antibodies Stock Price Chart Viracta Therapeutics Stock Price Chart Theratechnologies Stock Price Chart Receive ACXP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Acurx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ACXP) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBiden to Drop BOMBSHELL June 13th?Paradigm PressElon to Transform U.S. Economy? Porter & CompanyCharles Payne Demystifies OptionsUnstoppable ProsperityThe most important AI company you've never heard ofManward PressThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyElon’s New Device is About to Shock the WorldInvestorPlaceUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acurx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.